H World Group Limited American Depositary Shares vs Regeneron Pharmaceuticals Inc — how do they compare? H World Group Limited American Depositary Shares trades at $44.16 (market cap $13.25B), while Regeneron Pharmaceuticals Inc trades at $746.54 (market cap $76.14B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 5.7× H World Group Limited American Depositary Shares's market cap, and H World Group Limited American Depositary Shares pays the higher dividend (5.08%). Which is the better fit depends on your goals — on Pluang, investors hold H World Group Limited American Depositary Shares for 1 Days and Regeneron Pharmaceuticals Inc for 107 Days on average.
| HTHT | REGN | |
|---|---|---|
Market Cap | $13.25B | $76.14B |
Volume | 1,177,261 | 500,239 |
Sector | Consumer Cyclical | Health |
52-Week High | $56.06 | $852.03 |
52-Week Low | $36.99 | $557.73 |
Typical Hold Time | 1 Days | 107 Days |
Enterprise Value | $16.03B | $70.85B |
Dividend Yield | 5.08% | 0.51% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Regeneron Pharmaceuticals (REGN) trades at $739.57, down 0.34% with a bearish technical signal. The company maintains strong fundamentals with a 27.86% net income margin and consistent earnings beats. Recent news highlights a significant $8 billion immunology alliance expansion with Sanofi, providing substantial upfront payments and milestone potential. Cash flow improved significantly in 2025 with $635 million net cash flow versus negative flows in prior years.
The stock presents a compelling investment case with strong profitability, positive analyst sentiment (69% buy ratings), and a $849.84 consensus price target offering 15% upside. Key risks include competitive pressures in ophthalmology drugs and reliance on key partnerships. The expanded Sanofi collaboration and promising clinical pipeline provide catalysts for growth.
Trailing returns across standard periods
H World Group operates hotels through leased and owned, managed franchise, and franchise models. Its brands include HanTing, JI Hotel, Orange Hotel, and Steigenberger Hotels & Resorts.
Read more on HTHT →Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →